EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum sPD-L1 Levels in Early Pregnancy Predict Fetal Growth Restriction and Its Subtypes: A Prospective Nested Case–Control Study

Yao Wang iD, Yue Shi, Ruqun Zheng, Xiaoyi Bai, Maran Bo Wah Leung, Lai Kwan Lam iD, Chi Chiu Wang iD, Tak Yeung Leung iD

International Journal of Molecular Sciences · 02.06.2026 · 27 (11) · 5037

DOI: 10.3390/ijms27115037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.06.2026. Verfasst von Yao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Fetal Growth Retardation. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CUHK HOPE BWCH Collaborative Medical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fetal growth restriction (FGR) is a leading cause of perinatal morbidity and mortality, yet reliable first-trimester biomarkers for early prediction remain lacking. Growing evidence suggests that placental dysfunction is a central pathological driver of FGR. Therefore, placenta-derived proteins in maternal circulation may serve as mechanistically informative biomarkers for early detection. Here, we aimed to evaluate several placenta-relevant molecules as biomarkers for predicting isolated FGR and its subtypes. In this prospective nested case–control study, we included singleton pregnancies that underwent Down screening in the first trimester and were subsequently diagnosed with FGR (n = 50, including early-onset FGR [EFGR] and late-onset FGR [LFGR]) and healthy pregnancies (n = 100). Pregnancies with maternal comorbidities or fetal anomalies were excluded. Maternal serum protein concentrations were measured using ELISA kits. There were no significant differences in placenta-specific protein 1 (PLAC1) or netrin-1 between the two groups. By contrast, maternal soluble programmed death-ligand 1 (sPD-L1) levels were significantly lower in overall FGR (p < 0.001) and FGR subtypes (p = 0.002) than in controls. Circulating sPD-L1 levels were positively correlated with gestational age at delivery and birth weight Z score. Each one-unit increase in sPD-L1 was associated with lower odds of overall FGR (Odd ratio, OR 0.33), EFGR (OR 0.17), LFGR (OR 0.43), birth weight Z score 3–10% (OR 0.30), and neonatal intensive care unit (NICU) admission (OR 0.38). Moreover, first-trimester sPD-L1 predicted overall FGR (area under the receiver operating characteristic curve, AUC 0.75), EFGR (AUC 0.84), LFGR (AUC 0.70), birth weight Z score 3–10% (AUC 0.75), and NICU admission (AUC 0.67). Collectively, decreased maternal circulating sPD-L1 in early pregnancy may serve as a potential biomarker for isolated FGR, warranting validation in larger multicenter mechanistic studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Growth RetardationHumansFemalePregnancyCase-Control StudiesBiomarkersProspective StudiesAdultPregnancy Trimester, FirstGestational AgeROC CurvePregnancy ProteinsPlacenta

Stichwörter der Autor:innen

blood-based biomarkerdisease predictionfetal growth restrictionplacentapregnancy complicationsprogrammed death-ligand 1

Substanzen

BiomarkersPregnancy Proteins

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Hub of Obstetrics and Paediatric Excellence (HOPE), The Chinese University of Hong Kong, Hong Kong SAR, China.
  • The Chinese University of Hong Kong-Baylor College of Medicine Joint Centre for Medical Genetics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.

ORCID-Profile: Yao Wang, Lai Kwan Lam, Chi Chiu Wang, Tak Yeung Leung

Förderung

  • CUHK HOPE BWCH Collaborative Medical Research Fund

Zitieren

APA

Wang, Y., Shi, Y., Zheng, R., Bai, X., Leung, M. B. W., Lam, L. K., Wang, C. C., & Leung, T. Y. (2026). Serum sPD-L1 Levels in Early Pregnancy Predict Fetal Growth Restriction and Its Subtypes: A Prospective Nested Case–Control Study. International Journal of Molecular Sciences, 27(11), 5037. https://doi.org/10.3390/ijms27115037

Vancouver

Wang Y, Shi Y, Zheng R, Bai X, Leung MBW, Lam LK, et al. Serum sPD-L1 Levels in Early Pregnancy Predict Fetal Growth Restriction and Its Subtypes: A Prospective Nested Case–Control Study. International Journal of Molecular Sciences. 2026;27(11):5037. doi:10.3390/ijms27115037

BibTeX
@article{Wang2026,
  author = {Wang, Yao and Shi, Yue and Zheng, Ruqun and Bai, Xiaoyi and Leung, Maran Bo Wah and Lam, Lai Kwan and Wang, Chi Chiu and Leung, Tak Yeung},
  title = {Serum sPD-L1 Levels in Early Pregnancy Predict Fetal Growth Restriction and Its Subtypes: A Prospective Nested Case–Control Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {5037},
  doi = {10.3390/ijms27115037}
}
Kostenlos starten →